Across the Asia-Pacific, life‑sciences firms are forging strategic licensing partnerships to fast‑track innovation, seize surging regional demand, and navigate complex IP landscapes-moves that are rewriting growth trajectories and reshaping competitive dynamics
Southeast Asian governments are racing to embrace AI from U.S. tech giants – courting investment while ceding data access and regulatory control in a high-stakes bet that could deepen their dependence on foreign digital platforms
Asia Society’s new report probes the changing landscape of U.S.-China relations in the life sciences, where competition and collaboration increasingly intertwine. It highlights policy flashpoints, deep research linkages, and the wider implications for global health security